跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Iliadin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Iliadin
Approved
STANDARD
Iliadin
PT. Merck Tbk.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
541da5892a870e82
Company
PT. Merck Tbk.
Type
Standard
Approval Details
Approval Id
541da5892a870e82
Drug Approval Philippines Name
Iliadin
Product Name
Iliadin
Registration Number
DR-XY45124
Brand Name
Iliadin
Generic Name
Oxymetazoline Hydrochloride
Dosage Form
Nasal Spray
Dosage Strength
500 mcg/mL (0.05% w/v)
Manufacturer
PT. Merck Tbk.
Importer
Procter & Gamble Philippines, Inc.
Issuance Date
25 March 2021
Expiry Date
23 February 2026
Pharmacologic Category
Nasal Decongestant
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
541da5892a870e82
Type
Standard
Back to Philippines FDA Approvals